Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project

BACKGROUND: Chronic kidney disease has emerged as a strong cardiovascular risk factor, and in many current guidelines, it is already considered as a coronary heart disease (CHD) equivalent. Routinely, creatinine has been used as the main marker of renal function, but recently, cystatin C emerged as...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothenbacher, Dietrich, Rehm, Martin, Iacoviello, Licia, Costanzo, Simona, Tunstall-Pedoe, Hugh, Belch, Jill J. F., Söderberg, Stefan, Hultdin, Johan, Salomaa, Veikko, Jousilahti, Pekka, Linneberg, Allan, Sans, Susana, Padró, Teresa, Thorand, Barbara, Meisinger, Christa, Kee, Frank, McKnight, Amy Jayne, Palosaari, Tarja, Kuulasmaa, Kari, Waldeyer, Christoph, Zeller, Tanja, Blankenberg, Stefan, Koenig, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650190/
https://www.ncbi.nlm.nih.gov/pubmed/33161898
http://dx.doi.org/10.1186/s12916-020-01776-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650190/
https://www.ncbi.nlm.nih.gov/pubmed/33161898
http://dx.doi.org/10.1186/s12916-020-01776-7

Ejemplares similares